Alberta Cancer Foundation   Report issue

Foundation Phase 1 Phase 2 Phase 3
Founded: Edmonton Canada (1985)

Organization Overview

First Clinical Trial
1998
NCT00156858
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Alberta Cancerboard | Alberta Cancer Foundation